Zkusit zdarma
Apollo Endosurgery, Inc.

Apollo Endosurgery, Inc.

APEN
Cena:
 
 
Valuace
70
Růst
43
Zdraví
69

Výsledky Q3 2022

Načítám obsah…
Apollo Endosurgery, Inc., a medical technology company, focuses on the design, development, and commercialization of medical devices. The company offers OverStitch and OverStitch Sx Endoscopic Suturing Systems that enable advanced endoscopic procedures by allowing physicians to sutures and secure the approximation of tissue through a flexible endoscope.
It also provides Orbera, an intragastric balloon system that reduces stomach capacity causing patients to consume less following the procedure, as well as delays gastric content emptying under the Orbera Intragastric Balloon System, BIB, and Orbera365 Managed Weight Loss System brands. Additionally, the company offers X-Tack Endoscopic HeliX Tacking System, a suture-based device for closing and healing defects in the lower and upper gastrointestinal tract.
The company sells its products to medical services providers; and hospitals, outpatient surgical centers, clinics, and physicians in the United States, Australia, Costa Rica, and other European countries. Apollo Endosurgery, Inc. was founded in 2005 and is headquartered in Austin, Texas.
preloader

Prezentace a earnings calls Apollo Endosurgery, Inc. (APEN)

DatumNázevKvartálRok
01.11.2022APEN Q3 2022Q32022
02.08.2022APEN Q2 2022Q22022
03.05.2022APEN Q1 2022Q12022
01.11.2021APEN Q3 2021Q32021